Clinical Laserthermia Systems AB (publ) (CLS-B.ST)
- Previous Close
13.51 - Open
14.64 - Bid 13.77 x --
- Ask 14.00 x --
- Day's Range
13.50 - 14.64 - 52 Week Range
12.67 - 59.00 - Volume
10,035 - Avg. Volume
37,856 - Market Cap (intraday)
109.908M - Beta (5Y Monthly) 0.46
- PE Ratio (TTM)
0.14 - EPS (TTM)
100.95 - Earnings Date May 17, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
60.00
Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. The company offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. It also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers provides multiple options to control treatment. In addition, the company offers various gauge laser applicators, as well as provides temperature and treatment monitoring devices. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.
www.clinicallaser.seRecent News: CLS-B.ST
Performance Overview: CLS-B.ST
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CLS-B.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CLS-B.ST
Valuation Measures
Market Cap
109.91M
Enterprise Value
79.91M
Trailing P/E
0.14
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
11.52
Price/Book (mrq)
1.72
Enterprise Value/Revenue
9.85
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-77.72%
Return on Equity (ttm)
-314.73%
Revenue (ttm)
8.27M
Net Income Avi to Common (ttm)
-79.79M
Diluted EPS (ttm)
100.95
Balance Sheet and Cash Flow
Total Cash (mrq)
15.33M
Total Debt/Equity (mrq)
3.84%
Levered Free Cash Flow (ttm)
-46M
Research Analysis: CLS-B.ST
Company Insights: CLS-B.ST
CLS-B.ST does not have Company Insights